Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-0.15%
operating margin TTM
5.4%
revenue TTM
22.13 Million
revenue per share TTM
0.8$
valuation ratios | |
|---|---|
| pe ratio | -2,197.21 |
| peg ratio | -21.97 |
| price to book ratio | -27.93 |
| price to sales ratio | 3.31 |
| enterprise value multiple | 36.38 |
| price fair value | -27.93 |
profitability ratios | |
|---|---|
| gross profit margin | 93.3% |
| operating profit margin | 5.4% |
| pretax profit margin | -0.15% |
| net profit margin | -0.15% |
| return on assets | -0.16% |
| return on equity | 3.1% |
| return on capital employed | 6.69% |
liquidity ratio | |
|---|---|
| current ratio | 6.72 |
| quick ratio | 6.56 |
| cash ratio | 4.06 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 121.51 |
| operating cycle | 220.44 |
| days of payables outstanding | 329.58 |
| cash conversion cycle | -109.14 |
| receivables turnover | 3.69 |
| payables turnover | 1.11 |
| inventory turnover | 3.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.44 |
| debt equity ratio | -3.56 |
| long term debt to capitalization | 1.40 |
| total debt to capitalization | 1.39 |
| interest coverage | 0.63 |
| cash flow to debt ratio | 1.39 |
cash flow ratios | |
|---|---|
| free cash flow per share | 1.01 |
| cash per share | 0.99 |
| operating cash flow per share | 1.01 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 1.39 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Fennec Pharmaceuticals Inc. (NASDAQ:FENC) reported earnings?
Fennec Pharmaceuticals Inc. (FENC) published its most recent earnings results on 08-11-2024.
What is Fennec Pharmaceuticals Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Fennec Pharmaceuticals Inc. (NASDAQ:FENC)'s trailing twelve months ROE is 3.1%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Fennec Pharmaceuticals Inc. (FENC) currently has a ROA of -0.16%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did FENC's net profit margin stand at?
FENC reported a profit margin of -0.15% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is FENC's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 6.72 in the most recent quarter. The quick ratio stood at 6.56, with a Debt/Eq ratio of -3.56.